(VFEM) Vanguard FTSE Emerging - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00B3VVMM84
VFEM: Emerging, Markets, Equity, ETF, Tracking, Morningstar, Index
Vanguard FTSE Emerging Markets UCITS ETF (Ticker: VFEM) is a German-domiciled exchange-traded fund listed on XETRA, designed to track the performance of emerging markets equities. The fund replicates the Morningstar EM TME NR USD Index, providing exposure to a diversified portfolio of companies operating in emerging economies. As an ETF, it offers liquidity, transparency, and cost-efficiency, appealing to investors seeking broad emerging market equity exposure.
From a technical perspective, VFEM exhibits a moderate trading volume, with an average of 16,220 shares traded over the past 20 days. The ETF is currently priced at 54.60 EUR, slightly above its 20-day simple moving average (SMA) of 54.08 but below its 50-day SMA of 57.16. The 200-day SMA of 56.90 indicates a recent downtrend. The Average True Range (ATR) of 1.14 suggests moderate volatility, with price fluctuations averaging 2.08% over the past 20 days.
Fundamentally, VFEM manages an asset base of 2,706.58M EUR, indicating strong investor interest and liquidity. The funds scale allows for efficient tracking of its underlying index, with a focus on emerging markets equities. This exposure includes countries such as China, India, Brazil, and South Africa, providing diversification across key emerging economies.
3-Month Forecast: Based on the intersection of technical and fundamental data, VFEM is expected to face headwinds in the near term. The ETFs price is currently testing its 20-day SMA support level of 54.08, with resistance at the 50-day SMA of 57.16. The 200-day SMA of 56.90 acts as a key pivot point. The ATR of 1.14 suggests that volatility will remain moderate, with potential downside risks tied to broader emerging market instability. Fundamentally, while the AUM of 2,706.58M EUR underscores the funds stability, emerging market equities may face challenges from geopolitical tensions, currency fluctuations, and monetary policy shifts in developed markets. Overall, VFEM is projected to trade in a range between 52.50 and 58.00 over the next three months, with upside potential limited by macroeconomic uncertainties.
Additional Sources for VFEM ETF
VFEM ETF Overview
Market Cap in USD | 3,041m |
Category | Global Emerging Markets Equity |
TER | 0.22% |
IPO / Inception | 2012-05-22 |
VFEM ETF Ratings
Growth Rating | 35.0 |
Fundamental | - |
Dividend Rating | 47.5 |
Rel. Strength | -17.1 |
Analysts | - |
Fair Price Momentum | 53.21 EUR |
Fair Price DCF | - |
VFEM Dividends
Dividend Yield 12m | 2.60% |
Yield on Cost 5y | 3.57% |
Annual Growth 5y | 4.47% |
Payout Consistency | 94.7% |
Payout Ratio | % |
VFEM Growth Ratios
Growth Correlation 3m | -13.4% |
Growth Correlation 12m | 46.5% |
Growth Correlation 5y | 35.8% |
CAGR 5y | 6.34% |
CAGR/Max DD 5y | 0.29 |
Sharpe Ratio 12m | 0.55 |
Alpha | -0.49 |
Beta | 0.581 |
Volatility | 14.21% |
Current Volume | 6.8k |
Average Volume 20d | 8.5k |
As of June 01, 2025, the stock is trading at EUR 57.11 with a total of 6,839 shares traded.
Over the past week, the price has changed by -1.57%, over one month by +4.41%, over three months by -5.59% and over the past year by +6.97%.
Neither. Based on ValueRay´s Analyses, Vanguard FTSE Emerging is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 34.98 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VFEM is around 53.21 EUR . This means that VFEM is currently overvalued and has a potential downside of -6.83%.
Vanguard FTSE Emerging has no consensus analysts rating.
According to our own proprietary Forecast Model, VFEM Vanguard FTSE Emerging will be worth about 60.1 in June 2026. The stock is currently trading at 57.11. This means that the stock has a potential upside of +5.22%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 60.1 | 5.2% |